Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 733-736

  McConnell, Scott A ^a   Nafziger, Anne N ^a,b   Amsden, Guy W ^a,b  

^a Department of Pharmacy Services ^*  (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIRITHROMYCIN; THEOPHYLLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; THEOPHYLLINE BLOOD LEVEL;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DYSPEPSIA; ERYTHROMYCIN; FEMALE; HEADACHE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; THEOPHYLLINE; TREMOR;

EID: 0032949891     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.733     Document Type: Article

References (15)

1. Sides, G. D., Cerimele, B. J., Black, H. R., Busch, U. & DeSante, K. A. (1993). Pharmacokinetics of dirithromycin. Journal of Antimicrobial Chemotherapy 31, Suppl. C, 65-75.
2. Goldbert, M. J., Ring, B., DeSante, K., Cerimele, B., Hatcher, B., Sides, G. et al. (1996). Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo. Journal of Clinical Pharmacology 36, 1154-60.
3. Lindstrom, T. D., Hanssen, B. R. & Wrighton, S. A. (1993). Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers. Antimicrobial Agents and Chemotherapy 37, 265-9.
4. Jennings, T. S., Nafziger, A. N., Davidson, L. & Bertino, J. (1993). Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism. Journal of Laboratory and Clinical Medicine 122, 208-16.
5. Kelly, H. W. (1996). Mechanisms and principles of theophylline pharmacokinetic drug interactions. In Drug Interaction and Updates Quarterly, (Hansten, P. D. & Horn, J. R., Eds), p. 497. Applied Therapeutics, Inc., Vancouver, WA.
6. Bachmann, K., Nunlee, M., Martin, M., Sullivan, T. J., Jauregui, L., DeSante, K. et al. (1990). Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin. Journal of Clinical Pharmacology 30, 1001-5.
7. Watkins, P. B. (1992). Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterology Clinics of North America 21, 511-26.
8. Tanswell, P. & Koup, J. (1993). TopFit: a PC based pharmacokinetic/pharmacodynamic data analysis program. International Journal of Clinical Pharmacology, Therapy, and Toxicology 31, 514-20.
9. Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
10. Ramsdell, J. (1995). Use of theophylline in the treatment of COPD. Chest 107, Suppl., S206-9.
11. Weinberger, M. &Hendeles, L. (1996). Theophylline in asthma. New England Journal of Medicine 334, 1380-8.
12. Troger, U. & Meyer, F. P. (1995). Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline: focus on biotransformation. Clinical Pharmacokinetics 28, 287-314.
13. Larrey, D., Funck-Brentano, C., Breil, P., Vitaux, J., Theodore, C., Babany, G. et al. (1983). Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochemical Pharmacology 32, 1063-8.
14. Wrighton, S. A. & Stevens, J. C. (1992). The hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology 22, 1-21.
15. Bachmann, K., Jauregui, L, Sides, G. & Sullivan, T. J. (1993). Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin. Journal of Clinical Pharmacology 30, 861-5.